To compare the anti-tumor function of antibody treatment and HER2-redirected CAR T cells, we established subcutaneous JIMT-1 xenografts (3 × 106 cells) in SCID mice (day −35, Figure 4). The gene discussed is ERBB2; the disease is neoplasm.